Reducing homocysteine levels does not prevent stroke recurrence
BMJ 2004; 328 doi: https://doi.org/10.1136/bmj.328.7435.307 (Published 05 February 2004) Cite this as: BMJ 2004;328:307
- Scott Gottlieb
- New York
Among patients with a previous stroke, reducing levels of the amino acid homocysteine in the blood with high dose vitamin therapy does not reduce the risk of recurrent stroke.
Previous studies have shown an association between raised levels of total homocysteine and the risk of stroke and heart disease (Stroke 2004;35:169-74). Folic acid, pyridoxine (vitamin B-6), and cobalamin (vitamin B-12) are known to reduce plasma homocysteine levels, but the effectiveness of homocysteine lowering therapy to reduce the risk of stroke has not been confirmed by randomised trials.
Dr James Toole of Wake …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.